Morpheus8 Treatment Specialist in Barrington, IL

Morpheus8 is a radiofrequency microneedling treatment. The device uses small needles to enter the skin while delivering controlled RF energy into selected tissue depths. This combination creates a controlled treatment response that supports changes in collagen-rich tissue over time.

Regency Medical Spa offers Morpheus8 for cosmetic skin concerns involving the face and body. The treatment area, device settings, depth, and number of sessions are selected according to the individual rather than using the same approach for every client.

During treatment, the Morpheus8 applicator places small needles into the skin and delivers bipolar RF energy through the needle array. The RF energy creates controlled heating within the targeted tissue.

The FDA device documentation describes Morpheus8 as delivering fractional RF energy through coated needles, producing localized heating and coagulation in tissue that comes into direct contact with the needle tips. Research on RF microneedling also supports its use for changes in skin texture, wrinkles, firmness, and acne scarring, although individual outcomes vary.

Morpheus8 may be considered for several cosmetic concerns, including:

• Fine lines and wrinkles
• Uneven or rough skin texture
• Reduced skin firmness
• Certain types of acne scars
• Visible changes associated with skin aging

Regency Medical Spa currently offers Morpheus8 for skin rejuvenation concerns involving areas such as the face, neck, and body. The specific concern should be evaluated before treatment because not every skin condition or type of pigmentation is appropriate for RF microneedling.

Recent systematic reviews have found evidence supporting RF microneedling for facial rejuvenation, acne scarring, and skin texture improvement. Response varies according to the concern being treated, device parameters, treatment area, and individual skin characteristics.

There is no single number of sessions that applies to every client. Regency Medical Spa currently notes that a treatment plan may involve approximately two to four sessions, depending on the client’s skin concerns and treatment goals.

Changes may develop gradually because tissue remodeling does not occur immediately. Some patients may notice visible changes earlier than others, and additional treatments may be considered based on the response to the initial session.

The treatment schedule should therefore be determined after an assessment rather than based on a guaranteed number of sessions or a guaranteed timeline.

Morpheus8 can be used across a range of skin tones, but it should not be described as automatically appropriate for every person or every device setting.

Published research has evaluated RF microneedling in darker Fitzpatrick skin types and has reported a generally low rate of persistent pigment-related complications. However, temporary post-inflammatory hyperpigmentation can occur.

Device settings also matter. FDA documentation for Morpheus8 states that use at certain higher energy levels is limited to Fitzpatrick Skin Types I through IV. A qualified provider therefore needs to consider the client’s skin type, treatment area, medical history, and planned settings before proceeding.

Recovery varies by treatment intensity, treatment area, and individual skin response. Redness, swelling, warmth, tenderness, or temporary skin sensitivity can occur following RF microneedling. Research generally identifies redness and swelling among the most frequently reported short-term effects.

Clients should follow the aftercare instructions provided by their treating clinician. These may include keeping the area clean, limiting unnecessary sun exposure, using appropriate sun protection, and temporarily avoiding skincare products that could irritate the treated skin.

Clients should contact their treating provider if they develop unexpected or persistent symptoms after treatment.

A consultation is important before Morpheus8 because RF microneedling is not appropriate for everyone.

The FDA advises discussing relevant medical conditions, medications, active skin problems, and implanted devices before microneedling treatment. Factors requiring additional evaluation can include active skin infections, active rashes, bleeding disorders, immune suppression, uncontrolled diabetes, certain medications, a history of abnormal scarring, recent isotretinoin use, pregnancy or breastfeeding, and other medical conditions.

Morpheus8 device documentation also identifies certain implanted electronic or metallic devices, including pacemakers and internal defibrillators, as contraindications.

The FDA issued a safety communication after receiving reports of serious complications associated with certain uses of RF microneedling devices, including burns, scarring, changes in facial or body fat, nerve injury, and lasting changes in appearance. These reports make appropriate client selection, device settings, treatment technique, and follow-up especially important.

Aleksandra Bielawiec, DNP, NP, is a nurse practitioner and aesthetic master injector at Regency Medical Spa and Hair Restoration in Barrington, Illinois. Her professional background includes more than 14 years in dermatology and aesthetic medicine, along with experience in aesthetic assessment and treatment planning.

For clients considering Morpheus8, the treatment process should begin with an evaluation of the skin, treatment area, medical history, current medications, and cosmetic goals. This allows the Regency Medical Spa team to determine whether Morpheus8 is appropriate and to select treatment parameters based on the individual rather than applying a standard treatment plan to every patient.

Frequently Asked Questions

Clients can experience discomfort, warmth, or sensitivity during RF microneedling. The level of discomfort varies according to the treatment area and device settings. Clients should discuss comfort measures and what to expect with the treating clinician before the session.

Yes. Regency Medical Spa offers Morpheus8 for selected cosmetic concerns involving facial and body areas. The specific area should be evaluated before treatment to determine appropriate depth, settings, and treatment planning.

The timing varies. Some changes may become noticeable during the weeks following treatment, while collagen-related tissue remodeling can continue over a longer period. A specific result or timeline cannot be guaranteed.

Clients should provide an accurate medical history and disclose medications, active skin conditions, recent cosmetic treatments, implanted medical devices, bleeding problems, pregnancy or breastfeeding status, previous abnormal scarring, and any previous reactions to skin procedures.

U.S. Food and Drug Administration
U.S. Food and Drug Administration
PubMed — Effectiveness of Radiofrequency Microneedling in the Treatment of Dermatological Conditions: A Systematic Review
PubMed — Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy